Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Somatomedin C in pathogenesis of malignant exophthalmos of endocrine origin.

× No keyword cloud information.

7 in total

1. Octreotide and urinary glycosaminoglycan in Graves' disease.

Authors: T C Chang; W C Yao; C C Chang
Journal: BMJ Date: 1992-05-30

2. Octreotide and Graves' ophthalmopathy and pretibial myxoedema.

Authors: T C Chang; S C Kao; K M Huang
Journal: BMJ Date: 1992-01-18

Review 3. Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.

Authors: Terry J Smith; Joseph A M J L Janssen
Journal: Endocr Rev Date: 2019-02-01 Impact factor: 19.871

4. Locally produced insulin-like growth factor-1 by orbital fibroblasts as implicative pathogenic factor rather than systemically circulated IGF-1 for patients with thyroid-associated ophthalmopathy.

Authors: Delu Song; Renyan Wang; Yong Zhong; Weiye Li; Hui Li; Fangtian Dong
Journal: Graefes Arch Clin Exp Ophthalmol Date: 2011-12-09 Impact factor: 3.117

5. Insulin-like and fibroblast growth factors in spinal cords, nerve roots and skeletal muscle of human controls and patients with amyotrophic lateral sclerosis.

Authors: H Kerkhoff; S M Hassan; D Troost; R W Van Etten; H Veldman; F G Jennekens
Journal: Acta Neuropathol Date: 1994 Impact factor: 17.088

6. Rapid axoplasmic transport of insulin-like growth factor I in the sciatic nerve of adult rats.

Authors: H A Hansson; B Rozell; A Skottner
Journal: Cell Tissue Res Date: 1987-02 Impact factor: 5.249

Review 7. Somatostatin analogs: a new tool for the management of Graves' ophthalmopathy.

Authors: G E Krassas
Journal: J Endocrinol Invest Date: 2004-03 Impact factor: 4.256

7 in total